Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study comparing subcutaneous versus intravenous ublituximab in patients with relapsing multiple sclerosis

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Croatia Czechia Hungary
  • Study on Fenebrutinib and Teriflunomide for Adults with Relapsing Multiple Sclerosis

    Not recruiting

    3 1 1
    Investigated Diseases:
    Finland Germany Hungary Italy Poland Portugal +1
  • Study on Fenebrutinib for Patients with Relapsing Multiple Sclerosis

    Not recruiting

    2 1
    Investigated Diseases:
    Croatia Czechia Slovakia
  • Study on the Effects of Vidofludimus Calcium in Adults with Relapsing Multiple Sclerosis

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Estonia Germany Poland Romania
  • Study on Ublituximab and Drug Combination for Patients with Myasthenia Gravis or Relapsing Multiple Sclerosis

    Not recruiting

    1 1 1 1
    Poland
  • Study of LY3541860 and Meglumine Gadoterate for Adults with Relapsing Multiple Sclerosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    France Germany Italy Latvia Lithuania Poland +1
  • Study on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis

    Not recruiting

    3 1 1
    Investigated Diseases:
    Austria Belgium Bulgaria Croatia Denmark Ireland +7
  • Study on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis

    Not recruiting

    3 1 1
    Investigated Diseases:
    Bulgaria Croatia Czechia Estonia France Germany +9
  • Study on the Safety and Efficacy of BIIB091 and Diroximel Fumarate for Patients with Relapsing Multiple Sclerosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    Bulgaria Czechia Germany Italy Poland Romania +1
  • Study on the Effectiveness of Vidofludimus Calcium (IMU-838) in Adults with Relapsing Multiple Sclerosis

    Not recruiting

    3 1
    Investigated Drugs:
    Bulgaria Germany Lithuania Poland